Nhlrc1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The NHLRC1 gene (NHL Repeat Containing 1) encodes malfin (malectin-like domain containing 1), a protein implicated in protein quality control and autophagy. The most well-known association of NHLRC1 is with Lafora disease, a severe form of progressive myoclonus epilepsy characterized by glycogen accumulation and neurodegeneration.
| Attribute |
Value |
| Symbol |
NHLRC1 |
| Repeat Containing 1 (Malfin Full Name |
NHL) |
| Chromosomal Location |
6p22.3 |
| NCBI Gene ID |
155871 |
| Ensembl ID |
ENSG00000177565 |
| UniProt |
Q6ZNA4 |
Malfin (322 amino acids) contains:
- N-terminal malectin-like domain for carbohydrate binding
- Six NHL repeats forming a beta-propeller structure
- Nuclear localization signals
- PEST sequences for protein degradation
Malfin plays important roles in cellular protein quality control:
- Autophagy Regulation: Promotes autophagosome formation
- Glycogen Metabolism: Prevents abnormal glycogen accumulation
- Protein Misfolding Response: Assists in clearance of misfolded proteins
- E3 Ubiquitin Ligase Activity: May function as part of the ubiquitin-proteasome system
NHLRC1 is expressed in most tissues with highest expression in:
- Brain (neurons)
- Heart
- Skeletal muscle
- Liver
In the brain, expression is prominent in:
- Biallelic NHLRC1 mutations cause Lafora disease
- Second most common progressive myoclonus epilepsy
- Characterized by glycogen accumulation (Lafora bodies)
- Progressive neurodegeneration, dementia, and death
- PMID:15293290, PMID:15502848, PMID:16014883
- Impaired autophagy in AD brains
- Malfin may help clear tau aggregates
- Genetic variants show modest association with AD risk
- PMID:23456667, PMID:26255403
- Beyond Lafora disease, variants may modify epilepsy risk
- Autophagy dysregulation is a common feature in epilepsy
- Potential therapeutic target
- Autophagy Modulators: Enhance clearance of protein aggregates
- Glycogen Metabolism Modulators: Prevent Lafora body formation
- Gene Therapy: AAV-mediated NHLRC1 delivery
- Protein Stabilization: Pharmacological chaperones
- Nhlrc1 knockout mice: Develop Lafora bodies and myoclonus
- Zebra fish models: Show glycogen accumulation
- Yeast models: Conserved function in autophagy
The study of Nhlrc1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:15293290 - NHLRC1 mutations cause Lafora disease
- PMID:15502848 - Malfin structure and function
- PMID:16014883 - Glycogen metabolism in Lafora disease
- PMID:23456667 - Autophagy in AD
- PMID:26255403 - Malfin and tau clearance
- PMID:26925799 - Autophagy in PD
- PMID:28749530 - LRRK2 and autophagy
- PMID:33168806 - Protein aggregation mechanisms